featured
Long-Term Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
J. Clin. Oncol 2021 Apr 23;[EPub Ahead of Print], BM Eyck, JJB van Lanschot, MCCM Hulshof, BJ van der Wilk, J Shapiro, P van Hagen, MI van Berge Henegouwen, BPL Wijnhoven, HWM van Laarhoven, GAP Nieuwenhuijzen, GAP Hospers, JJ Bonenkamp, MA Cuesta, RJB Blaisse, OR Busch, GM Creemers, CJA Punt, JTM Plukker, HMW Verheul, EJ Spillenaar Bilgen, MJC van der Sangen, T Rozema, FJW Ten Kate, JC Beukema, AHM Piet, CM van Rij, JG Reinders, HW Tilanus, EW Steyerberg, A van der GaastFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.